ATP1A1-Related Autosomal Dominant Charcot-Marie-Tooth Disease Type 2

ATP1A1-related autosomal dominant Charcot-Marie-Tooth disease type 2 is a rare inherited nerve disease. It happens when there is a harmful change (mutation) in a gene called ATP1A1. This gene gives the body instructions to make part of the sodium-potassium pump (Na⁺/K⁺-ATPase), a protein that helps nerve cells keep the right balance of salts (ions) inside and outside the cell. Frontiers+2ResearchGate+2

ATP1A1-related autosomal dominant Charcot-Marie-Tooth disease type 2 (also called CMT2DD or ATP1A1-related CMT2) is a very rare inherited nerve disease. It mainly damages the long nerves to the feet and hands. This causes slowly progressive weakness, muscle wasting, balance problems and reduced feeling in the legs and arms. Most people stay able to walk, but they may need braces or other support devices in later life.Global Genes+1 This condition is caused by a disease-causing change (mutation) in the ATP1A1 gene. This gene gives the instructions for part of the sodium-potassium pump (Na⁺/K⁺-ATPase), a protein that controls salt balance and electrical activity in nerve cells. When ATP1A1 does not work properly, the long axons of motor and sensory nerves become sick and slowly degenerate, leading to an axonal type of Charcot-Marie-Tooth disease (CMT2).PMC+2Wiley Online Library+2

Because of the ATP1A1 mutation, the pump does not work properly. When the pump is weak, nerve cells cannot keep a normal electrical signal. Over time, the long parts of the nerves (axons) are damaged. This slow damage to the axons of the peripheral nerves (nerves of the arms and legs) causes muscle weakness, loss of feeling, and foot and hand problems. This pattern of disease is called Charcot-Marie-Tooth type 2 (CMT2), which is mainly an axonal neuropathy. ScienceDirect+2Europe PMC+2

This condition is autosomal dominant. That means a person can get the disease when they have one changed copy of ATP1A1 from one parent. Sometimes the mutation is de novo, which means it appears for the first time in the child and is not found in the parents. PubMed+2PMC+2

Most people develop symptoms in childhood, the teen years, or early adult life. The disease usually gets worse slowly over many years. It mainly affects the feet and legs first and may later affect the hands. Mayo Clinic+2MedlinePlus+2

---

Other Names

Doctors and researchers may use several names for this same condition. These names are based on the gene and the type of neuropathy: PubMed+2PMC+2

• ATP1A1-related Charcot-Marie-Tooth disease

• ATP1A1-related CMT type 2

• ATP1A1-related axonal Charcot-Marie-Tooth neuropathy

• ATP1A1-related intermediate Charcot-Marie-Tooth disease

• Dominant ATP1A1-associated CMT2

• Hereditary motor and sensory neuropathy due to ATP1A1 mutation (ATP1A1-HMSN)

These are all descriptive names. They all refer to a hereditary peripheral neuropathy caused by a disease-causing change in the ATP1A1 gene. Frontiers+2ResearchGate+2

---

Types

Doctors sometimes talk about “types” or patterns within ATP1A1-related CMT. These types are based on how the disease looks in real patients and how strongly the nerve tests are changed: Springer+2Frontiers+2

• Pure ATP1A1-related axonal CMT2 – main problems are slowly progressive weakness and wasting of muscles in feet and hands, with reduced feeling, and nerve tests showing axonal damage.

• Intermediate ATP1A1-related CMT – nerve conduction speeds are in the “intermediate” range (not clearly demyelinating, not clearly normal), but signs and symptoms still look like CMT2.

• Complex ATP1A1-related neuropathy – some patients have peripheral neuropathy plus extra problems such as spasticity, seizures, or learning difficulty. These extra features reflect broader effects of the ATP1A1 mutation on the nervous system. American Academy of Neurology+2Wiley Online Library+2

Not every doctor will use exactly the same labels, but they all describe the same core problem: a genetic, ATP1A1-related peripheral neuropathy. Charcot-Marie-Tooth Association+1

---

Causes

Remember: the main true cause of this disease is a harmful mutation in one copy of the ATP1A1 gene. The 20 items below explain this cause and related biological mechanisms and patterns in simple points. PubMed+2PMC+2

1. Pathogenic ATP1A1 mutation
   The direct cause is a disease-causing change in the ATP1A1 gene. This change alters the code for the alpha-1 subunit of the sodium-potassium pump, so the protein cannot work normally in nerve cells. Frontiers+2Physiological Journals+2

2. Loss of sodium-potassium pump function
   The sodium-potassium pump uses energy (ATP) to move sodium out of the cell and potassium into the cell. A faulty ATP1A1 protein makes this pump weak or “leaky,” so nerve cells cannot keep a healthy ion balance. ResearchGate+2Physiological Journals+2

3. Abnormal ion flow through the pump
   Some ATP1A1 mutations not only reduce pump strength but also allow abnormal ion flow through the protein. This can cause unwanted currents and disturb the electrical state of the nerve cell membrane. Physiological Journals+2ScienceDirect+2

4. Membrane depolarization of nerve cells
   Because of the poor pump function, the inside of the nerve cell becomes less negative than normal (depolarized). This makes it harder for the nerve to fire signals over long distances and increases stress on the axon. Physiological Journals+1

5. Axonal degeneration of peripheral nerves
   Over time, the stressed nerve fibers in arms and legs start to wear out and break down. This axonal degeneration is the main tissue change seen in CMT2-type diseases, including ATP1A1-related CMT2. ScienceDirect+2Europe PMC+2

6. Damage to long motor neurons
   Motor neurons that run from the spinal cord to the feet and hands are very long. They need strong pumps to keep signals going. When ATP1A1 is faulty, these long neurons are affected first, causing weakness and wasting of distal muscles. PubMed+2ScienceDirect+2

7. Damage to sensory neurons
   The sensory nerves that carry touch, pain, and vibration signals also depend on a healthy sodium-potassium pump. ATP1A1 mutations can damage these axons, so patients lose feeling, especially in feet and toes. NCBI+2MedlinePlus+2

8. Effect on Schwann cells
   Schwann cells wrap around peripheral axons and support them. ATP1A1 is present in Schwann cells as well. A harmful change in ATP1A1 may disturb Schwann cell function and further harm the axons, even if the myelin looks only mildly abnormal. PMC+1

9. Dominant-negative or haploinsufficient effect
   In autosomal dominant disease, one changed copy can be enough to cause problems. The mutant protein may interfere with the normal copy (dominant-negative) or there may simply not be enough healthy pump activity (haploinsufficiency). ResearchGate+2Physiological Journals+2

10. Mitochondrial stress in muscle and nerve
    Chronic ion imbalance and depolarization can stress mitochondria (the “power houses” of the cell). Some CMT2 forms show disturbed mitochondrial maintenance in muscle. Similar processes may occur in ATP1A1-related CMT2. NCBI+2ScienceDirect+2

11. Genetic inheritance from an affected parent
    Many patients inherit the ATP1A1 mutation from a parent who also has CMT symptoms, sometimes milder. Each child of an affected parent has a 50% chance to receive the mutation. PubMed+2Europe PMC+2

12. New (de novo) mutation in the child
    In some families, the mutation appears for the first time in the child, with no prior history in the parents. This happens when a DNA change arises in the egg or sperm or early embryo. Wiley Online Library+2PubMed+2

13. Background of other CMT genes (genetic modifiers)
    Many genes can cause or modify CMT. If a person has small changes in other neuropathy genes, these may not cause disease alone but may slightly worsen or change the picture when an ATP1A1 mutation is present. ScienceDirect+2NCBI+2

14. Age-related accumulation of axonal damage
    The disease is slowly progressive. With time, the repeated stress on axons from poor pump function leads to more fiber loss. This is why older patients often show more weakness and disability than younger ones. JAMA Network+2ScienceDirect+2

15. Possible interaction with metabolic stress (such as long-term diabetes or toxin exposure)
    ATP1A1-related CMT2 is genetic, not caused by lifestyle. But extra stresses on nerves, such as poorly controlled diabetes or certain toxins, may worsen symptoms in a person who already has an ATP1A1 mutation. University of Rochester Medical Center+2Mayo Clinic+2

16. Effect on central nervous system in some variants
    Some ATP1A1 mutations are linked not only to peripheral neuropathy but also to seizures or spasticity. This shows that the same pump defect can also disturb brain and spinal cord cells in a subset of patients. Frontiers+2Physiological Journals+2

17. Ion imbalance leading to cell swelling or injury
    When sodium builds up inside cells and potassium balance is lost, water can follow, and cells may swell or become fragile. Over long periods, this can contribute to axon injury. Physiological Journals+2ResearchGate+2

18. Changes in signaling pathways inside the cell
    The sodium-potassium pump also helps control other cell signals. When the pump is faulty, signaling pathways that regulate growth, survival, and repair in neurons may be disturbed, increasing nerve vulnerability. Physiological Journals+2Frontiers+2

19. Low capacity for nerve repair
    Peripheral nerves can repair to some degree, but constant stress from the pump defect may exceed the repair capacity. Over years, this leads to more permanent axonal loss and chronic neuropathy. ScienceDirect+2Europe PMC+2

20. Overall genetic background and chance
    The exact severity in each person depends on the specific ATP1A1 variant and the person’s whole genetic background. Some variants cause mild CMT, others cause more severe or complex disease. This variation is often called the “phenotypic spectrum.” Springer+2PubMed+2

---

Symptoms

Not everyone has all symptoms, and they can be mild or severe. But these are common symptoms seen in ATP1A1-related CMT2 and in similar CMT2 forms. PubMed+4Mayo Clinic+4MedlinePlus+4

1. Weakness in feet and ankles
   The first sign is often trouble lifting the front part of the foot (foot drop). People may trip often, cannot run as before, and feel their ankles are weak. Mayo Clinic+2University of Rochester Medical Center+2

2. High arches or other foot deformities
   Many people develop pes cavus (very high arch) or hammertoes. These changes happen slowly because muscles around the foot are not balanced in strength. Mayo Clinic+2University of Rochester Medical Center+2

3. Thin lower legs (“stork-like” legs)
   As muscles waste away in the calves, the lower legs can look thin compared with the thighs. This is due to long-term denervation (loss of nerve supply) of these muscles. NCBI+2Europe PMC+2

4. Numbness or reduced feeling in feet and toes
   Many patients feel tingling, pins and needles, or numbness in their feet. They may not feel small injuries or changes in temperature very well. Mayo Clinic+2MedlinePlus+2

5. Weakness in hands and fingers
   As the disease progresses, hand muscles can also become weak. People may have trouble with fine movements such as buttoning clothes, writing, or opening jars. NCBI+2Europe PMC+2

6. Loss of vibration sense and position sense
   The ability to feel vibration (for example from a tuning fork) and know where the feet are in space can be reduced. This loss of “proprioception” can make balance worse, especially in the dark. NCBI+2Europe PMC+2

7. Reduced or absent tendon reflexes
   Knee and ankle jerks are often weak or absent when checked with a reflex hammer. This reflects damage to the peripheral nerves carrying the reflex arc. NCBI+2Europe PMC+2

8. Difficulty with walking and running
   Because of weakness, foot drop, and loss of feeling, people may walk with a steppage gait (lifting knees high) and get tired easily. Running and sports can become difficult. Mayo Clinic+2University of Rochester Medical Center+2

9. Balance problems and falls
   When both strength and sensation are reduced, balance becomes poor. Patients may sway when they stand with eyes closed and may fall on uneven ground. Mayo Clinic+2NCBI+2

10. Neuropathic pain or discomfort
    Some people feel burning, electric shocks, or deep aching in their feet or legs. This “nerve pain” is due to damaged sensory fibers sending abnormal signals. Mayo Clinic+2University of Rochester Medical Center+2

11. Fatigue with daily activities
    Because the muscles work less efficiently and nerves are damaged, simple tasks like walking short distances or climbing stairs can cause tiredness and heaviness in the legs. JAMA Network+2Mayo Clinic+2

12. Hand tremor or clumsiness (in some patients)
    A few people with CMT have mild tremor or feel clumsy when doing fine tasks. This may be due to both weakness and sensory loss in the upper limbs. NCBI+2Europe PMC+2

13. Cramps and muscle twitching
    Muscles that are weak or losing nerve supply may cramp or twitch. These sudden tight feelings can be painful but usually last a short time. NCBI+2ScienceDirect+2

14. Mild scoliosis or posture changes
    In some inherited neuropathies, the spine or posture can change slightly due to long-term muscle imbalance. This is not present in everyone but may be seen in some cases. NCBI+2Europe PMC+2

15. Extra signs in complex ATP1A1 variants (for some people)
    In a minority of patients with specific ATP1A1 mutations, there can be extra problems such as spasticity (stiff muscles), seizures, or learning difficulties in addition to the neuropathy. Frontiers+2American Academy of Neurology+2

---

Diagnostic Tests

Doctors use several types of tests to diagnose ATP1A1-related CMT2. These tests help show that there is a peripheral neuropathy and then confirm that the ATP1A1 gene is the cause. PubMed+4NCBI+4Mayo Clinic+4

Physical Exam (Examples included in items)

1. Full neurological history and examination
   The doctor asks detailed questions about walking, balance, hand use, age at onset, and family history. They then examine strength, sensation, reflexes, and gait. A pattern of slowly progressive distal weakness and sensory loss in more than one limb suggests CMT rather than a single nerve injury. NCBI+2Mayo Clinic+2

2. Inspection of feet, legs, and hands
   The doctor looks for high arches, hammertoes, thin calves, and hand muscle wasting. These visible signs of chronic denervation are common in CMT and help distinguish it from acute nerve damage. Mayo Clinic+2University of Rochester Medical Center+2

3. Muscle strength testing by manual resistance
   The examiner checks how strong each muscle group is by asking the patient to move against resistance. In CMT2, distal muscles (ankle, foot, hand) are usually weaker than proximal muscles (hip, shoulder). This pattern supports an axonal neuropathy. NCBI+2Europe PMC+2

4. Sensory testing for touch, pain, temperature, and vibration
   The doctor uses cotton, a pin, cool/warm objects, and a tuning fork to check feeling in the feet and hands. Reduced sensation in a stocking-and-glove pattern is typical for hereditary motor and sensory neuropathy like CMT. NCBI+2MedlinePlus+2

Manual Tests (Bedside Functional Tests – items )

5. Deep tendon reflex testing with a reflex hammer
   Using a small hammer, the doctor taps the tendons at the knee and ankle. Weak or absent reflexes in multiple limbs suggest a length-dependent peripheral neuropathy rather than a brain or spinal cord problem alone. NCBI+2Europe PMC+2

6. Gait analysis and heel/toe walking test
   The patient is asked to walk normally, then on heels, then on toes. People with CMT often cannot walk on heels because of foot drop and may lift their knees high (steppage gait). This simple test shows distal weakness clearly. Mayo Clinic+2University of Rochester Medical Center+2

7. Romberg test for balance
   The patient stands with feet together, first with eyes open, then closed. If they lose balance easily with eyes closed, it suggests poor position sense from sensory nerve damage, which is common in CMT. NCBI+2Europe PMC+2

8. Manual muscle testing of hands and fingers
   The doctor asks the patient to spread fingers, pinch, and grip while providing resistance. Weakness of the small hand muscles, out of proportion to more central muscles, supports a peripheral neuropathy such as ATP1A1-related CMT2. NCBI+2Mayo Clinic+2

Lab and Pathological Tests

9. Basic blood tests to rule out acquired neuropathy
   Tests such as blood sugar, vitamin B12, thyroid function, and kidney and liver tests are often done. Normal results support a genetic cause like CMT, while abnormal results might point to a different, treatable neuropathy. Mayo Clinic+2University of Rochester Medical Center+2

10. Electrolyte tests including magnesium and potassium
    Some ATP1A1 mutations are linked to electrolyte problems such as hypomagnesemia. Checking electrolytes helps see whether the mutation has effects beyond the nerves and may provide extra clues about ATP1A1 dysfunction. Physiological Journals+2Frontiers+2

11. Creatine kinase (CK) and other muscle enzymes
    CK can be mildly raised in some neuropathies because weak muscles are stressed. Normal or only slightly raised CK is more typical for neuropathy than for primary muscle disease, helping to narrow the diagnosis. ScienceDirect+2Europe PMC+2

12. Nerve biopsy (for selected, unclear cases)
    A small piece of a sensory nerve (often the sural nerve) can be removed and studied under a microscope. In CMT2, the main finding is axonal loss rather than thickened myelin. Today, biopsy is less common because genetic testing is available. Europe PMC+2ScienceDirect+2

13. Muscle biopsy (when mitochondrial or muscle changes are suspected)
    In some forms of CMT2, muscle biopsy can show disturbed mitochondrial structure. If doctors see unusual features on MRI or have other reasons to suspect extra muscle problems, they may perform this test to better understand the disease. NCBI+2ScienceDirect+2

14. Genetic testing panel for CMT genes
    A blood sample is sent to a lab that tests many CMT-related genes at once. If a disease-causing ATP1A1 variant is found, this confirms the diagnosis of ATP1A1-related CMT2. Genetic counseling is then offered to the family. NCBI+2ARUP Consult+2

Electrodiagnostic Tests

15. Nerve conduction studies (NCS)
    Small electrical impulses are given to nerves, and the responses are recorded. In ATP1A1-related CMT2, nerve conduction velocities are often normal or only mildly slow, but the response size is reduced, showing axonal loss. Europe PMC+2ScienceDirect+2

16. Electromyography (EMG)
    A thin needle electrode is placed into muscles to record their electrical activity. EMG in CMT2 often shows signs of chronic denervation and re-innervation, supporting a long-standing axonal neuropathy. Europe PMC+2ScienceDirect+2

17. Late responses (F-waves and H-reflexes)
    These are special parts of nerve conduction tests that look at long pathways. Abnormal F-waves or H-reflexes in several limbs further support a generalized peripheral neuropathy. Europe PMC+2ScienceDirect+2

18. Quantitative sensory testing (QST)
    This test uses controlled warmth, cold, and vibration to measure sensory thresholds. It can show early sensory loss even when routine testing is less clear and helps track changes over time in hereditary neuropathies. ScienceDirect+2NCBI+2

Imaging Tests

19. MRI of brain and spinal cord (for complex cases)
    In most people with pure ATP1A1-related CMT2, MRI of the brain and spine is normal. However, if there are seizures, spasticity, or other central signs, MRI can look for extra changes and help rule out other conditions. Frontiers+2Physiological Journals+2

20. Ultrasound or MRI of peripheral nerves and muscles
    High-resolution ultrasound or MRI of nerves and muscles can show nerve thinning or muscle wasting. These imaging tools are mainly research or specialist tools but can support the diagnosis of a chronic inherited neuropathy. ScienceDirect+2University of Rochester Medical Center+2

Non-pharmacological treatments (therapies and other approaches)

Below are 20 key non-drug treatments commonly used in CMT2, including ATP1A1-related CMT2. They do not cure the disease but they can strongly improve function, comfort and quality of life.

1. Individualized physiotherapy program
Physiotherapy is one of the most important treatments for CMT. A trained physiotherapist designs safe exercises to keep muscles as strong and flexible as possible and to protect joints from stiffness and contractures. Low-impact activities like stretching, gentle strengthening, cycling, or swimming can improve walking, balance and endurance. The therapist also checks posture and gait and gives tips to reduce fatigue and falls.nhs.uk+2Physiopedia+2

2. Stretching and range-of-motion exercises
Daily stretching of ankles, calves, hamstrings, hips, fingers and wrists helps prevent muscles and tendons from shortening. In CMT2, tight calf muscles and Achilles tendon can make it hard to put the heel on the floor, worsening foot deformity and balance. Gentle, regular stretching keeps joints moving smoothly and lowers the risk of contractures and pain. A physiotherapist teaches safe techniques that can be done at home.Physiopedia+1

3. Muscle-strengthening exercises
Targeted strengthening focuses on muscles that are weak but still able to respond, especially around the hips, knees, shoulders and core. Light resistance bands, ankle weights or water exercises can be used. The goal is to support unstable joints and compensate for the very weak small muscles in the feet and hands. Over-training is avoided because it can over-stress fragile axons.Physiopedia+2Charcot-Marie-Tooth Disease+2

4. Balance and gait training
CMT2 often causes balance problems and a “steppage” gait because of foot drop and loss of sensation. Balance training uses simple tasks like standing on different surfaces, changing directions, or practicing safe turning. Gait training teaches safer walking patterns and sometimes practice with braces, canes or walkers. This reduces falls and builds confidence in daily activities.nhs.uk+2Muscular Dystrophy Association+2

5. Occupational therapy for hand and daily-life skills
Occupational therapists help with hand weakness, reduced fine motor control and fatigue. They can teach joint-protection techniques, suggest adapted grips, utensils, keyboards and dressing aids, and show energy-saving strategies for work and home. This supports independence in eating, writing, using a phone, self-care and work tasks.Charcot-Marie-Tooth Association+1

6. Orthotic devices (braces, splints and special shoes)
Ankle-foot orthoses (AFOs), high-top shoes, custom insoles and thumb or wrist splints are often used in CMT2. They stabilize weak joints, reduce foot drop, support high arches and prevent ankle sprains. Properly fitted devices can transform walking comfort and safety. Orthotists and physiotherapists review and adjust these regularly as the disease changes.Mayo Clinic+2nhs.uk+2

7. Assistive walking devices
Canes, trekking poles, walkers or rollators may be needed if balance and strength fall below a safe level. Using these tools is not a failure; it is a way to stay active while protecting yourself from serious falls and fractures. Doctors and therapists help choose the right device and teach safe use indoors and outdoors.PMC+1

8. Foot care and podiatry
Because sensation is reduced, small foot injuries may go unnoticed and can become serious. Regular podiatry visits, proper nail cutting, callus care, and daily self-inspection of the feet help prevent ulcers and infections. Proper shoes with a wide toe box and soft insoles protect bony, high-arched feet and hammertoes.Mayo Clinic+2Muscular Dystrophy Association+2

9. Pain-management techniques (non-drug)
Massage, heat, ice, transcutaneous electrical nerve stimulation (TENS), acupuncture, relaxation therapy and gentle yoga may lessen neuropathic pain and muscle discomfort. While the scientific evidence is mixed and usually modest, many patients report useful relief when these methods are combined with medical care.U.S. Food and Drug Administration+2Charcot-Marie-Tooth Association+2

10. Aquatic therapy (pool exercises)
Water supports body weight and reduces joint stress, making movement easier and safer. Pool-based programs can improve strength, flexibility, balance and confidence with a lower risk of falls. Warm water can also relax tight muscles and reduce pain. A physiotherapist can design a program matched to the person’s abilities.Charcot-Marie-Tooth Disease+1

11. Home and workplace modifications
Handrails, grab bars, non-slip flooring, raised toilet seats, ramps, and proper lighting reduce risk of accidents. At work, ergonomic chairs, footrests, voice-to-text software, and flexible scheduling can help manage fatigue and physical limits. Occupational therapists often visit home or work sites to suggest practical changes.Muscular Dystrophy Association+1

12. Genetic counseling and family planning support
Because ATP1A1-related CMT2 is autosomal dominant, families often want clear information on inheritance, risks to children, and prenatal or pre-implantation genetic options. Genetic counselors explain test results in simple language, discuss emotional issues, and help families make informed choices that match their values.PMC+2PubMed+2

13. Psychological counseling and support groups
Living with a rare, chronic disease can cause anxiety, low mood, or worry about the future. Counseling or cognitive-behavioral therapy (CBT) can help people manage pain, fatigue and uncertainty. Patient organizations (such as the Charcot-Marie-Tooth Association and Hereditary Neuropathy Foundation) offer online communities, education and emotional support.Global Genes+2Charcot-Marie-Tooth Association+2

14. Sleep hygiene and fatigue management
Chronic pain and muscle cramps may disturb sleep, and weak muscles make daily tasks more tiring. Good sleep habits, pacing activities, planning rest breaks and using energy-saving strategies can reduce exhaustion. Sometimes a sleep study is needed if breathing problems or restless legs are suspected.U.S. Food and Drug Administration+1

15. Regular monitoring and early complication management
Routine neurologic review, foot checks, orthopaedic assessments and physical therapy reassessments allow early detection of new problems such as increasing foot deformity, severe contractures, or new pain patterns. Treating issues early with splints, therapy or surgery often gives better long-term results than waiting.PMC+2Mayo Clinic+2

---

Drug treatments for ATP1A1-related CMT2

There is no approved drug that directly treats ATP1A1-related CMT2. Current medicines focus on neuropathic pain, muscle cramps, mood, sleep and other symptoms, using general neuropathic pain guidelines. Choices and doses must be tailored by a specialist.PMC+2Charcot-Marie-Tooth Association+2

Below are 10 important drug options commonly discussed for neuropathic pain and symptoms in CMT (fewer than 20 because of space; each is an example, not a recommendation):

1. Duloxetine (SNRI antidepressant)
Duloxetine is a serotonin-norepinephrine re-uptake inhibitor (SNRI) approved by the FDA for diabetic peripheral neuropathic pain, some chronic pain conditions, depression and anxiety. Typical adult doses for neuropathic pain are around 60 mg once daily, based on FDA labeling.PMC+3FDA Access Data+3FDA Access Data+3 It reduces pain by increasing serotonin and norepinephrine in pain-modulating pathways in the brain and spinal cord. Common side effects include nausea, dry mouth, sleepiness, dizziness and sweating.

2. Pregabalin (gabapentinoid)
Pregabalin is a gabapentinoid that binds to the α2δ subunit of voltage-gated calcium channels. It is approved for neuropathic pain associated with diabetic neuropathy, post-herpetic neuralgia and spinal cord injury, as well as certain seizure types.FDA Access Data+2FDA Access Data+2 Adult doses for neuropathic pain are often in the range 150–600 mg per day, divided into 2–3 doses, adjusted for kidney function. It may cause dizziness, drowsiness, weight gain and swelling.

3. Gabapentin (gabapentinoid)
Gabapentin also targets the α2δ calcium channel subunit and is widely used off-label for many neuropathic pain conditions, although its main FDA indication is post-herpetic neuralgia and as add-on therapy in epilepsy.FDA Access Data+2FDA Access Data+2 Dosing is usually slowly increased over days to reduce side effects such as dizziness and sleepiness. It can help burning, shooting and tingling pain in peripheral neuropathy, including CMT-related pain.

4. Tricyclic antidepressants (e.g., amitriptyline, nortriptyline)
Tricyclic antidepressants (TCAs) like amitriptyline have long been used in low night-time doses for neuropathic pain. They block re-uptake of serotonin and norepinephrine and have additional receptor actions that reduce pain signals. Evidence shows that only a minority get strong relief, but many patients gain partial benefit.FDA Access Data+2FDA Access Data+2 Side effects include dry mouth, constipation, weight gain, drowsiness and, rarely, heart rhythm problems, so ECG monitoring may be needed.

5. Serotonin-norepinephrine re-uptake inhibitors other than duloxetine (e.g., venlafaxine)
Venlafaxine and similar SNRIs are sometimes chosen when duloxetine is not tolerated or when mood symptoms are strong. They act by enhancing serotonin and norepinephrine, which changes pain processing. Evidence for neuropathic pain is more limited than for duloxetine, and they share similar side effects such as nausea, blood pressure changes and withdrawal symptoms if stopped suddenly.Charcot-Marie-Tooth Association+1

6. Topical lidocaine (patches or gels)
Lidocaine 5% patches or gels can be placed on areas of focal neuropathic pain, such as very sensitive spots on the feet. They block sodium channels in small nerve fibers to reduce abnormal firing. Because absorption into the bloodstream is low, systemic side effects are usually mild, making them useful in people who cannot tolerate oral drugs.Charcot-Marie-Tooth Association+1

7. Topical capsaicin (high-concentration patch or cream)
Capsaicin, derived from chili peppers, depletes substance P and other pain-related chemicals from small nerve endings. High-concentration patches applied under medical supervision can give long-lasting pain relief in some neuropathic conditions, although burning during application is common. Over-the-counter low-dose creams may help mild focal pain.Charcot-Marie-Tooth Association+1

8. Non-steroidal anti-inflammatory drugs (NSAIDs)
Simple pain killers like ibuprofen or naproxen may help musculoskeletal pain from overworked muscles and joints, but they usually do not strongly help true neuropathic pain. Doctors may still use them for short periods for cramps, joint strain or post-surgical pain, while checking for stomach, kidney and cardiovascular side effects.Muscular Dystrophy Association+1

9. Muscle relaxants (e.g., baclofen, tizanidine)
Some people with CMT2 develop troublesome muscle cramps or spasticity-like stiffness. Medicines such as baclofen or tizanidine can reduce over-active stretch reflexes and muscle tone. They act on spinal cord receptors (GABA-B for baclofen, α2-adrenergic for tizanidine). Side effects can include sleepiness, weakness and low blood pressure, so doses must be adjusted carefully.Muscular Dystrophy Association+1

10. Medicines for mood, sleep and anxiety
Pain, disability and uncertainty can cause depression, anxiety and poor sleep. Besides pain-modifying antidepressants, doctors may use other antidepressants, sleep aids like melatonin, or anti-anxiety medicines when clearly needed. Treating mental health can reduce pain perception and improve overall function. These drugs must be selected carefully to avoid worsening balance or causing dependence.U.S. Food and Drug Administration+2PMC+2

Because of space, many other drugs (for example, different anti-epileptic agents or analgesics) are not listed. For CMT2, experts usually start with one of the main neuropathic pain drug classes above and adjust according to effect and side effects.Charcot-Marie-Tooth Association+1

---

Dietary molecular supplements

There is no vitamin or supplement proven to cure ATP1A1-related CMT2, but good nutrition supports general nerve and muscle health. Evidence is often small or indirect, and any supplement should be discussed with a doctor to avoid interactions.

1. Vitamin B12 (cobalamin)
Vitamin B12 is essential for healthy myelin and nerve function. True B12 deficiency can cause a separate neuropathy, so doctors often check levels and replace deficiency with tablets or injections. Correcting deficiency can improve nerve conduction and prevent further damage, but it does not reverse hereditary CMT2.PMC+1

2. Vitamin B1 (thiamine) and B-complex
Thiamine plays a role in nerve energy metabolism. Severe deficiency (beriberi) causes neuropathy. A balanced B-complex supplement may be used if diet is poor, but high doses of vitamin B6 can themselves cause neuropathy, so balanced dosing under medical guidance is important.PMC+1

3. Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. Studies suggest it may reduce burning pain and improve nerve blood flow in that setting, although results are modest. Its role in hereditary CMT is unclear, but some clinicians may consider a trial in selected patients.PMC+1

4. Omega-3 fatty acids (fish oil)
Omega-3 fatty acids have anti-inflammatory and membrane-stabilizing effects. They may benefit cardiovascular health and possibly support nerve membranes, though high-quality evidence in CMT is lacking. Typical supplemental doses are in the range used for heart health, adjusted for bleeding risk and other conditions.PMC+1

5. Vitamin D
Vitamin D affects bone strength, muscle function and immune regulation. Low vitamin D levels are common in people with reduced mobility. Correcting deficiency supports bone health and may indirectly improve muscle function and fall risk, though it does not modify the genetic neuropathy itself.PMC+1

6. Coenzyme Q10
Coenzyme Q10 is involved in mitochondrial energy production. Some small studies in mitochondrial diseases suggest modest benefits. In hereditary neuropathies, evidence is limited, but some clinicians may consider it as an adjunct in patients with fatigue, with careful discussion about cost and expectations.PMC+1

7. Acetyl-L-carnitine
Acetyl-L-carnitine helps transport fatty acids into mitochondria. Studies in chemotherapy-induced neuropathy suggest possible nerve-protective effects, but data are not strong. It is sometimes used experimentally in hereditary neuropathies as part of a broader plan.U.S. Food and Drug Administration+1

8. Magnesium
Magnesium is important for muscle relaxation and nerve function. If blood magnesium is low, replacing it can reduce cramps and muscle twitching. Over-supplementation can cause diarrhea and, in kidney disease, high blood magnesium, so doses must be individualized.PMC+1

9. Curcumin (turmeric extract)
Curcumin has anti-inflammatory and antioxidant properties and is being studied in various chronic inflammatory conditions. Evidence for hereditary neuropathy is limited to preclinical models and small human series. If used, it should be seen as an experimental adjunct, not a main treatment.PMC+1

10. General multivitamin and healthy diet
For many people, the most realistic “supplement” is a balanced multivitamin combined with a varied, whole-food diet rich in fruits, vegetables, whole grains and lean proteins. This supports overall health, immune function and wound healing, which indirectly benefits people living with CMT2.Mayo Clinic+1

---

Immune-booster, regenerative and stem-cell-related drugs

For ATP1A1-related CMT2, there are currently no approved immune-booster or stem-cell drugs that have been proven to help and are recommended in guidelines. Research in CMT in general is exploring gene therapies, neurotrophic factors and stem-cell approaches, but these are still in early clinical trials or pre-clinical stages and not standard care.PMC+1

Because this disease is not autoimmune, powerful immune-suppressing or immune-modulating drugs used in inflammatory neuropathies (like IVIG, steroids or rituximab) are not routinely used and may be harmful if used incorrectly. The most realistic “immune support” is vaccination, good sleep, stress management, exercise within limits, and healthy diet.PMC+1

Some experimental strategies under study for CMT subtypes (not specifically ATP1A1 yet) include antisense oligonucleotides, gene replacement, and cell-based therapies aiming to rescue or replace sick Schwann cells or axons. These should only be used inside properly designed clinical trials, after careful counseling about risks and unknowns.PMC+1

---

Surgeries for ATP1A1-related CMT2

Surgery in CMT2DD does not fix the gene problem but can correct deformities and improve function or reduce pain.

1. Foot deformity correction (osteotomy and tendon balancing)
High-arched feet and hammertoes can make walking painful and unstable. Orthopaedic surgeons may cut and realign bones (osteotomy) and move tendons to rebalance pull on the foot. The goal is a flatter, more stable foot that fits into normal shoes and braces and reduces calluses, ulcers and ankle sprains.Mayo Clinic+2Muscular Dystrophy Association+2

2. Tendon transfer for foot drop
In severe foot drop, a stronger tendon (such as tibialis posterior) can be re-routed to the front of the foot to help lift it during walking. This can reduce the need for braces in some people and improve gait efficiency. Surgeons choose candidates carefully based on remaining muscle strength and balance.PMC+1

3. Joint fusion (arthrodesis)
When joints in the midfoot or ankle become very unstable or painful, fusion surgery may be used to permanently join bones together in a better position. This sacrifices some motion, but improves stability and allows safer walking or brace use. It is usually considered after less invasive options have failed.PMC+1

4. Corrective surgery for hand deformities
In selected patients with severe hand weakness and clawing, tendon transfers or joint releases may improve grip and hand position. Hand surgeons and occupational therapists then work together on post-operative rehabilitation to help the patient gain the most function.Charcot-Marie-Tooth Association+1

5. Decompression surgery for entrapment neuropathies
People with CMT may also develop common nerve entrapments such as carpal tunnel or ulnar nerve compression, which can add extra weakness and numbness. In such cases, decompression surgery to release the compressed nerve may provide improvement. Decisions are individualized based on electrodiagnostic tests and clinical findings.PMC+1

---

Prevention and lifestyle

You cannot prevent the genetic change in ATP1A1, but you can prevent or reduce some complications:

1. Avoid neurotoxic drugs such as certain chemotherapy agents or very high-dose vitamin B6, which can worsen neuropathy.

2. Protect feet and skin with daily inspection, proper shoes and quick treatment of blisters or cuts.

3. Prevent falls by using braces, canes or walkers when needed and by removing home hazards.

4. Stay physically active within limits using gentle, regular exercise and avoiding over-fatigue.

5. Maintain healthy weight to reduce stress on weak muscles and joints.

6. Manage other health problems, especially diabetes, thyroid disease and vitamin deficiencies, which can add extra nerve damage.

7. Keep vaccinations up to date, including flu and pneumonia as advised, to reduce serious illness that might further weaken you.

8. Do not smoke, as smoking reduces blood flow to nerves and worsens healing.

9. Limit alcohol, which can cause its own neuropathy and interact with medicines.

10. Attend regular follow-up visits with neurology, physio and orthopaedics so changes can be caught early.Mayo Clinic+2Muscular Dystrophy Association+2

---

When to see doctors urgently

People with ATP1A1-related CMT2 should keep regular appointments, but certain signs mean you should seek medical help sooner:

• Sudden or fast-worsening weakness, especially if it reaches hips, arms or breathing muscles.

• New trouble swallowing, speaking, or breathing, especially at night.

• Rapid increase in falls or loss of ability to walk usual distances.

• Severe, new or changing pain that is not controlled with your usual plan.

• Signs of serious foot or leg infection (redness, warmth, swelling, fever, open sores).

• New bladder or bowel control problems.

These could signal complications or another superimposed problem that needs urgent attention.Muscular Dystrophy Association+2Global Genes+2

---

What to eat and what to avoid

What to eat more of

1. Colorful fruits and vegetables – provide vitamins, antioxidants and fiber that support general health and healing.

2. Whole grains – such as brown rice, oats and whole-wheat bread for steady energy and better blood sugar control.

3. Lean proteins – fish, poultry, beans, lentils, tofu and eggs to support muscle repair.

4. Healthy fats – nuts, seeds, olive oil and fatty fish (rich in omega-3) to support cell membranes.

5. Calcium and vitamin D sources – dairy, fortified plant milk, leafy greens and safe sunlight to protect bones, especially if mobility is reduced.Mayo Clinic+1

What to limit or avoid

6. Sugary drinks and highly processed sweets, which can worsen weight and blood sugar control and may indirectly harm nerves.

7. Trans fats and very high saturated fat, found in some fried and fast foods, which hurt cardiovascular health.

8. Excess alcohol, which can directly damage nerves and interact with medicines used for neuropathic pain.

9. Very high doses of single vitamins without medical advice, especially vitamin B6, which can cause neuropathy.

10. Crash diets or extreme restrictions, which risk malnutrition and muscle loss in someone who already has muscle weakness.Muscular Dystrophy Association+2PMC+2

---

Frequently asked questions (FAQs)

1. Is ATP1A1-related CMT2 curable?
No. At present there is no cure and no drug that repairs the ATP1A1 gene. Treatment focuses on symptom control, prevention of complications and maintaining function with rehab, orthotics, medicines and sometimes surgery.PMC+1

2. Will I always be able to walk?
Most reported people with ATP1A1-related CMT2 stay ambulatory into later life, though many need braces, supportive shoes or walking aids. How fast symptoms progress varies a lot between people. Early physiotherapy and good foot care help preserve mobility.Global Genes+1

3. Does exercise make the disease worse?
Properly supervised, low-impact exercise is helpful, not harmful. Over-straining very weak muscles may not be useful, but gentle strengthening, stretching and aerobic activity support joint health, balance and mood. A CMT-experienced physiotherapist can design a safe program.Physiopedia+2Charcot-Marie-Tooth Disease+2

4. Can children with ATP1A1-related CMT2 do sports?
Many children can take part in adapted sports and physical education, with adjustments for tiredness and safety. Swimming, cycling and non-contact activities are usually easier than high-impact running or jumping. Regular review with paediatric neurology and physiotherapy is important.Charcot-Marie-Tooth Disease+2Muscular Dystrophy Association+2

5. Will medicines like duloxetine or pregabalin stop the nerve damage?
No. These medicines reduce neuropathic pain but do not change the underlying genetic disease. They act on chemical signaling in the nervous system to make pain signals less intense. The goal is better comfort and sleep, not cure.Charcot-Marie-Tooth Association+2FDA Access Data+2

6. Are pain medicines safe for long-term use?
Many neuropathic pain medicines can be used long term under careful supervision, with regular checks for side effects such as weight gain, mood changes, swelling or effects on heart rhythm. Opioids are usually avoided or kept to short courses because of dependence and side-effect risks.U.S. Food and Drug Administration+2PMC+2

7. Do I need genetic testing?
Genetic testing confirms the exact subtype and can be important for family planning and for future eligibility in gene-targeted trials. If you already have a known ATP1A1 mutation in your family, testing can identify who has inherited it. A genetic counselor can guide this process.PMC+2PubMed+2

8. Can stem-cell therapy or “regenerative injections” bought online help?
Unregulated stem-cell clinics are risky and often provide no proven benefit. For CMT, cell-based therapies are still experimental and should only be received within approved clinical trials at specialist centers, not in commercial clinics.PMC+1

9. Could diet alone fix my neuropathy?
Diet can improve energy, weight, and overall health, and can correct vitamin deficiencies that could otherwise add extra nerve damage. But diet cannot repair a genetic ATP1A1 mutation. It is one supportive part of care, not a cure.Mayo Clinic+2PMC+2

10. Is pregnancy safe for someone with ATP1A1-related CMT2?
Many women with CMT2 have successful pregnancies. Some experience temporary worsening of symptoms due to weight gain and hormonal changes. Planning pregnancy with a neurologist, obstetrician and genetic counselor helps address inheritance risks and delivery planning.Muscular Dystrophy Association+2PMC+2

11. Can this disease affect my heart or breathing?
ATP1A1-related CMT2 mainly affects peripheral nerves. Severe axonal neuropathy in some CMT types can occasionally involve breathing muscles or cause scoliosis that affects lungs, but this seems less common in CMT2DD. Any new shortness of breath or sleep-related breathing issues should be assessed promptly.PMC+1

12. Are there clinical trials I can join?
CMT clinical trials are ongoing worldwide, though many focus on more common subtypes. Rare types like ATP1A1-related CMT2 may eventually be included as gene-targeted strategies expand. ClinicalTrials.gov and CMT patient organizations can help locate possible studies.Global Genes+2PMC+2

13. Will surgery mean I will never need braces again?
Sometimes foot surgery reduces brace needs, but often braces are still useful after healing. The main goals are better alignment, pain relief and easier shoe fitting. Decisions should be made with an orthopaedic surgeon experienced in neuromuscular deformities.Mayo Clinic+2Muscular Dystrophy Association+2

14. Is it safe to drive with CMT2?
Many people with CMT can drive safely, sometimes with car adaptations like hand controls or left-foot accelerators. Laws and requirements vary by country. An occupational therapist and driving assessment service can advise on safety and necessary modifications.Muscular Dystrophy Association+1

15. What is the most important thing I can do today?
The most powerful steps are simple: stay engaged in regular physiotherapy, protect your feet, use braces or aids if needed, manage pain and mood with your doctors, and maintain a healthy lifestyle. Early, steady, supportive care usually leads to better long-term quality of life in ATP1A1-related CMT2.PMC+2Muscular Dystrophy Association+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.